Information connectivity
Discuss how diagnostic information and clinical workflows could connect within a platform engagement.
AI Health Platform is part of AMG’s technology and health platforms capability.
The deck describes Axon Healtrics and an AI technology platform intended to connect screening information, products and ongoing care. Its ambition is to turn diagnostic data into structured insights and anti-aging protocol support within the wider ecosystem.

Discuss how diagnostic information and clinical workflows could connect within a platform engagement.
Explore the intended role of AI in report interpretation and solution support, with appropriate professional oversight.
Ask the team about current deployment status, integration scope and partnership opportunities.
Roadmap context: the 27 August 2026 deck planned pilot clinics in Q3 2026 and full platform operation in December 2026. These are source-plan milestones; current rollout status must be confirmed with AMG.
Tell us what you need. We will connect you with the relevant business so you can confirm the right arrangements.
Let us know your interest in ai health platform and the questions you would like to discuss.
AMG can direct the enquiry to Axon Healtrics AI.
The business will confirm scope, availability and any practical requirements with you.
A few practical details about making an enquiry.
The deck gives December 2026 as the planned full-operation milestone. This page does not confirm that deployment has occurred; contact AMG for current status.
This page describes a technology direction, not an autonomous diagnosis or prescribing service. Clinical decisions require appropriate professional oversight.
Yes. Describe the workflow, systems and objectives in a partnership enquiry. The team can then assess scope and feasibility.